Traditional theories on facial aging and methods for rejuvenation focus primarily on soft tissues with ptosis as the major mechanism responsible for senescent changes. Anatomic studies demonstrate that there are also many changes to the craniofacial skeleton as patients age. Midface skeletal augmentation, using implants made of porous polyethylene, is a simple and effective method to reverse age-related changes of the facial skeleton in patients with intact occlusion. Skeletal implants correct concave morphology by increasing projection and provide a means to resuspend cheek soft tissues that have descended off a deficient bony platform. Beyond rejuvenation, skeletal implants can be used to restore facial proportions in patients with midface deficiency secondary to trauma, congenital deformity, or other pathologic states.
Traditional concepts of midface aging focus on soft tissue ptosis, secondary to gravitational forces, as the major mechanism responsible for senescent changes. Although clinically apparent long before, Yousif et al objectively documented using photogrammetry that with advancing age there is anterior and inferior descent of the cheek mass with deepening of the nasolabial fold. 1 This data along with empiric observations on facial aging provides a rationale for current face-lifting techniques that remove excess skin and resuspend deep soft tissues. 2, 3 Recent studies suggest that ptosis explains only a portion of the soft tissue changes associated with facial aging. Lambros' longitudinal photographic analysis of 103 patients spanning an average period of 25 years demonstrates that the lid-cheek junction, brow, and soft tissue landmarks such as nevi remain fixed in position in a significant proportion of patients with advancing age. 4 Lambros and others conclude that changes in volume of cheek fat, either loss or gain, rather than ptosis account for an aged appearance. As such, their techniques for rejuvenation include injections with either autologous fat or allogenic fillers. 5, 6 The aforementioned studies address soft tissue changes only; however, a comprehensive analysis of facial aging reveals that the craniofacial skeleton undergoes many changes as individuals mature. Early studies of facial bone growth suggested the craniofacial skeleton grew until skeletal maturity, but data from more recent studies do not support this theory. 7, 8 Israel demonstrated in a longitudinal radiogrammetric study that the skull, cranial base, and upper facial compartment increased from adulthood into senescence of the order 5 to 7%. 9 Behrents' thesis on longitudinal craniofacial skeletal morphology concluded that growth rates decelerated but continued into the oldest age spans. 10 Bartlett et al in a cross-sectional cohort analysis of 160 skulls from the Smithsonian Institution observed that facial width, depth, and height either increased or remained unchanged in older cohorts. 11 These studies do not address specific anatomic facial regions but taken together support that skull growth continues, albeit at varying rates, from infancy through late adulthood.
The clinical implications of skeletofacial aging are revealed in studies of relevant anatomic areas. Using a cross-sectional cohort design, Pessa and Shaw independently observed retrusion of the lower maxilla in patients from older compared with younger cohorts. 12, 13 Pessa suggests that maxillary retrusion is a principal factor in development of a prominent nasolabial fold in cases of maxillary hypoplasia, Crouzon syndrome, or as part of normal facial aging. In a separate study of periorbital aging, Pessa measured that the orbital rim and anterior cheek mass lie posterior to the corneal surface in older compared with younger patients (Fig. 1 ). 14 Citing the work of Jelks, Pessa concludes that the increased incidence of negative vector proportions in older patients contributes to complications after periorbital surgery. 15 Other anatomic studies demonstrate an enlarged orbital aperture in older individuals due to curve distortion of the superomedial and inferolateral orbital rim. 16, 17 The authors postulate that orbital remodeling has aesthetic implications by leading to formation of crow's-feet and lower lid lag. A summary of age-related changes to the midfacial skeleton based on data from available studies is depicted in Fig. 2 .
Although further research needs to be performed, age-related changes to both the overlying soft tissues and craniofacial skeleton have implications for reconstructive and aesthetic surgeons who attempt to effectively restore and rejuvenate facial appearance. Prior to undertaking surgical procedures on the face, surgeons must assess for changes at both lamella with intervention directed at the appropriate level. The current report describes the senior author's technique and indications for infraorbital rim, paranasal, and malar implant augmentation of the midface skeleton. It provides a rationale for hard tissue replacement in both facial rejuvenation and correction of a dysesthetic appearance in a subset of patients with acquired and congenital deformities.
SURGICAL TECHNIQUE

Anesthesia
General anesthesia is preferred. This approach allows adequate airway protection, surgical access, and intraoral cleansing.
Access
Infraorbital rim implants are placed through an intraoral upper sulcus and lower eyelid incisions. Both incisions are required for degloving of the midface soft tissues and infraorbital nerve visualization. The retroseptal transconjunctival incision is preferred to a preseptal approach to avoid delamination of the lower lid and scarring along the septal plane. The lateral canthotomy extension of the transconjunctival incision is avoided because it causes rounding of the lateral canthus and contributes to prolonged palpebral edema. In patients requiring a lateral canthopexy, a lateral extent of a blepharoplasty incision is added in a crow's-feet rhytide to access the zygomaticofrontal suture for a bridge of bone canthopexy (see later).
When indicated, malar and paranasal implants can be placed at the same time as infraorbital implants or used independently. Malar augmentation is performed through intraoral and lateral extent of blepharoplasty incisions. The blepharoplasty incision permits screw fixation of the implant over the proximal zygomatic arch. Placement of paranasal implants requires an intraoral incision.
Soft Tissue Mobilization
Through the access incisions, the midface soft tissues are widely undermined in the subperiosteal plane along the maxilla, extending laterally to the proximal zygomatic arch. This permits en bloc vertical resuspension of the soft tissues and lower lid while creating adequate space for an infraorbital implant.
In patients requiring a canthopexy, an additional temporal incision may be necessary for redistribution of temporal soft tissues. Performed beneath the superficial layer of the deep temporal fascia, this dissection proceeds until the zygomatic arch and lateral orbital rim are reached.
Implant Placement
The infraorbital implant (Porex Surgical, Newman, GA) is the most important implant to correct midface deformities, achieving 3 to 5 mm of anterior projection (Fig. 3 ). The implant flange allows stabilization on the anterior edge of the orbital floor and provides an area for screw fixation. Up to three implants, including paranasal and malar, may be necessary depending on the aesthetic needs of the patient. To closely follow the complex contour of the midface and avoid infraorbital nerve impingement, use of multiple implants is preferable to use of a single large implant. Specific paranasal implants placed along the piriform aperture have been designed ( Fig. 4) . 18 If the area lateral or inferior to the infraorbital implant is hollow, a malar implant is fashioned ( Fig. 5 ). Implants are fixed to the skeleton with titanium screws and contoured in situ with a burr for seamless transition with the skeleton and adjacent implants.
Lateral Canthopexy
Lateral canthopexy is indicated for patients with lid malposition and shape distortion of the lateral canthus after blepharoplasty or with a congenitally low-lying lateral canthus. Through the lateral extent of the lower blepharoplasty incision, the zygomatic frontal suture is exposed with drill holes placed 2 mm above and at the suture itself. A figure-of-eight, 30-gauge titanium wire suture is then passed through the lateral canthus with each end placed through the holes in the lateral orbital wall. The ends of the wire are twisted around the bridge of bone and secured behind the lateral orbital rim. 19 The final lateral canthus position should lie 2 to 3 mm above the medial canthal plane.
Soft Tissue Elevation
Two sutures are used to elevate the cheek and lower lid soft tissues. Sutures are placed in the periosteum adherent to the midface soft tissue, 3 cm below both the midpupillary line and lateral canthus. The midpupil suture is secured to the infraorbital rim implant, whereas the lateral suture is passed through either the lateral aspect of the infraorbital implant or a drill hole in the lateral orbital rim.
For patients who undergo lateral canthopexy, the temporal soft tissues are undermined and redistributed to avoid bunching that may occur in the region along the lateral upper lid or brow margin. Remaining excess tissue can be excised through either a lateral brow lift or upper lid blepharoplasty incisions.
Closed suction drains are placed beneath the soft tissues and brought out through a stab incision in the temporal scalp or retroauricular area. A temporary tarsorrhaphy is placed to minimize chemosis. Postoperative antibiotics are continued for 5 days.
Clinical Examples
Preoperative and postoperative photographs of patients who have undergone skeletal augmentation with porous polyethylene midfacial implants are shown in Figs. 6 and 7 .
DISCUSSION
Midface concavity may be the clinical end point of either pathologic or nonpathologic craniofacial processes. It may reflect a deformity secondary to an underlying craniosynostosis syndrome such as Apert or Crouzon syndrome, trauma, extreme forms of skeletal variation, or be part of normal facial aging. Whereas Lefort I and III osteotomies with advancement are used to restore facial proportions and occlusion in patients with craniofacial dysostoses, other etiologies of midface concavity can be 
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Patients with midface concavity have premature and exaggerated signs of aging. 14, [19] [20] [21] [22] They appear tired due to the presence of long lower eyelids, loss of cheek prominence, rounding of the lateral canthal angle, and increased vertical height of the palpebral fissure. The mechanism whereby midface skeletal deficiency contributes to these overlying soft tissue changes is unclear, but it may be that decreased bony projection hastens the gravitational descent of an unsupported soft tissue envelope. 14 An alternate hypothesis is proposed by Levine et al who contend that soft tissue descent is the ''engine'' driving the aging process with bone relocation and reshaping determined by the pull of surrounding soft tissues. 23 Regardless of the pathophysiologic mechanism, skeletal augmentation provides a means to effectively restore facial convexity and reestablish a platform whereby facial soft tissues can be supported.
Skeletal facial implants facilitate conversion of concave into convex faces in two ways. By augmenting skeletally deficient areas, projection is increased. Depending upon the indication, multiple implants may be needed to restore facial proportions. Second, subperiosteal midface resuspension, performed at time of infraorbital augmentation, has both direct and indirect effects.
Direct elevation of tissues through suspension sutures restores cheek fullness, which is abnormally positioned in aging or various pathologic states. Indirect changes are notable in the periorbital region where restoration of cheek bulk secondarily elevates the cheek-lid junction. This restores features of a youthful periorbita such as a short lower eyelid, narrow palpebral fissure, and with the use of a lateral canthopexy an acute lateral canthal angle. 19, 24, 25 Although clinicians commonly assess the face in the coronal plane, indications for skeletal augmentation, particularly infraorbital implants, are best understood by examination in the sagittal view. Patients with midface deficiency, regardless of etiology, have an altered sagittal globe-orbital rim relationship. 14, 26 The clinical relevance of the sagittal globe-orbital rim relationship was recognized indirectly by Rees and LaTrenta who measured an association between patients with prominent eyes, scleral show, maxillary hypoplasia or lower lid hypotonia and dry eye symptoms after blepharoplasty. 27 These patients were considered ''morphologically prone'' to dry eye symptoms and required special operative considerations. Jelks and Jelks in 1993 more formally defined the sagittal globeorbital rim relationship and suggested unfavorable results after blepharoplasty in patients with ''negative vector'' proportions. 15 The authors define ''negative vector'' morphology as a malar eminence that lies posterior to the globe surface, whereas a ''positive vector'' is when the malar eminence lies anterior to the globe surface. More recently, Pessa and others have shown that aging contributes to the negative vector deformity through posterior positioning of the inferior orbital rim and anterior maxillary wall (Fig. 2) . [12] [13] [14] 28 Figures 1 and 6 demonstrate correction of the negative vector deformity using infraorbital rim augmentation. Infraorbital rim implants are indicated as part of facial rejuvenation or for correction of midface deficiency, prominent eyes, and palpebral distortion after lower blepharoplasty. [19] [20] [21] 29 Paranasal and malar implants are recommended for patients with lower midface concavity who would benefit from Lefort I advancement but have intact occlusion. Although paranasal and malar implants are commonly combined with infraorbital rim implants ( Fig. 7) , either can be used in isolation. 18 Paranasal augmentation with or without rhinoplasty is described for patients with nasomaxillary deficiency such as Binder syndrome. 30, 31 Similarly, patients with cleft lip may have an altered lip and nasal relationship from prior surgery or abnormal maxillary growth, which can be corrected by paranasal implants. Asians and African Americans are a subset of ethnic patients with flat facial profiles or large noses, which can be effectively camouflaged with implants placed along the piriform aperture. Whitaker reported on 106 patients who underwent malar augmentation alone for midface hypoplasia. 32 Implants were placed from the region lateral to the piriform to the zygomatic arch. Indications included aesthetic improvement in greater than 50% and reconstruction for either hemifacial microsomia or posttraumatic deformity in most other patients.
Midface projection can be restored through use of either bone grafts or alloplastic materials. Bone grafts are unpredictable because the entirety of graft may not revascularize or once incorporated becomes subject to osteoclastic activity that is under the influence of deforming forces (Wolff's law). 33 In addition, bone grafts have associated donor-site morbidity such as pain and contour irregularities as well as the increased cost of operative time necessary for harvesting. Alloplastic materials are preferable because they are stable and lack donor-site morbidity.
Various alloplastic materials can be used for facial augmentation. Unlike smooth implants, which generate capsules that can irreversibly distort soft tissues, porous polyethylene due to its pore size of 100 to 250 mm tends to have improved tissue in-growth and revascularization through its pores. 34 The low infection and extrusion rates associated with porous polyethylene may be due to soft tissue in-growth. 35 Porous polyethylene as a biomaterial has good handling properties such that once fixed in position, it can be carved and contoured in situ using a burr.
Reliable and reproducible technical results with facial augmentation can be achieved by screw fixation using multiple implants. Use of more than one implant allows precise adaptation to the curvature of the face without gaps, which lead to unanticipated excess augmentation. Multiple implants also avoids impingement on the infraorbital nerve. Screw fixation prevents secondary movement of the implant and aids in situ contouring at junctions with the skeleton and other implants.
In conclusion, skeletal augmentation is a useful tool for surgeons to either restore or rejuvenate facial appearance in patients with congenital, acquired, or aesthetic deformities. Use of alloplastic material is straightforward and affords the surgeon an opportunity to resuspend soft tissues that have descended on a hypoplastic skeletal platform. Although the indications for augmentation in pathologic states may not change significantly in the years to come, as more is learned about skeletal aging in larger longitudinal studies, there may be an expanding role for skeletal augmentation in facial rejuvenation.
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